Core Insights - IHS Holding Limited reported solid revenue growth and free cash flow generation for the full year 2025, with a revenue increase of 3.6% year-on-year to $1,582.0 million and adjusted EBITDA growth of 9.0% to $1,012.3 million [2][9][47] - The company experienced a significant increase in adjusted levered free cash flow (ALFCF), which rose by 47.3% to $448.1 million, despite a decrease in cash from operations in the fourth quarter [9][52] - The company announced strategic divestitures, including the sale of its Latin American tower operations and a stake in I-Systems, which were classified as discontinued operations [4][40] Financial Highlights - Full year revenue from continuing operations was $1,582.0 million, up 3.6% from $1,527.2 million in 2024, with organic revenue growth of 10.1% [2][45] - Adjusted EBITDA for the full year was $1,012.3 million, reflecting a 9.0% increase year-on-year, while income for the period was $126.8 million compared to a loss of $1,644.2 million in 2024 [3][47] - Cash from operations for the full year was $983.0 million, an increase of 26.7% from $775.9 million in 2024 [3][51] Fourth Quarter Highlights - Revenue for the fourth quarter was $397.8 million, a 1.2% increase year-on-year, despite a 5.8% inorganic revenue headwind from the disposal of Kuwait operations [21][25] - Adjusted EBITDA for the fourth quarter was $249.8 million, up 1.4% year-on-year, while the company reported a loss of $83.5 million due to an impairment of discontinued operations [23][24] - ALFCF for the fourth quarter decreased by 19.3% to $86.5 million, primarily due to increased net interest payments and maintenance capex [25][52] Operational Highlights - The company had a total of 37,590 towers and 54,874 tenants at the end of the fourth quarter, with a colocation rate of 1.46x [13][21] - The company repaid high-interest debt facilities in Nigeria and Brazil, resulting in a net reduction in debt of $154 million [13] - The company announced a proposed sale of IHS Towers to MTN Group Limited for an enterprise value of approximately $6.2 billion, highlighting a strategic partnership [15][60] Capital Expenditure - Total capital expenditure for the fourth quarter was $79.1 million, down 4.3% year-on-year, primarily due to lower capital expenditure in the Latin American segment [41][42] - Capital expenditure in Nigeria increased by 19.3% year-on-year, reflecting higher maintenance and other capital expenditures [43][44] Segment Performance - Revenue from Nigeria increased by 4.0% year-on-year to $269.1 million, while segment adjusted EBITDA rose by 9.5% to $169.7 million [27][31] - The SSA segment saw a revenue increase of 3.6% to $128.7 million, but adjusted EBITDA declined by 8.6% to $73.8 million due to increased costs [32][34] - The Latin America segment reported revenue of $49.7 million, an increase of 11.4% year-on-year, with adjusted EBITDA decreasing by 1.4% to $36.6 million [37][39]

Core Insights - Thermo Fisher Scientific Inc. is focused on sustainable long-term growth through strategic acquisitions and strong performance in key end markets, although it faces challenges from foreign exchange fluctuations and competitive pressures [1][9]. Financial Performance - Over the past year, Thermo Fisher's stock has decreased by 2.4%, while the industry has declined by 4.3%, and the S&P 500 has increased by 21.9% [2]. - The company has a market capitalization of $192.62 billion and an earnings yield of 4.8%, significantly higher than the industry's negative 0.7% [2]. - Thermo Fisher has consistently exceeded earnings estimates in the last four quarters, achieving an average surprise of 2.8% [2]. Growth Drivers - Strength in the pharma and biotech end market has led to high single-digit growth in the fourth quarter of 2025, primarily due to the expansion of biosciences and bioproduction businesses to meet global vaccine manufacturing needs [4]. - The Industrial and Applied end market also showed growth, supported by strong performance in the research and safety market channel and electron microscopy business [5]. - The Diagnostics and Healthcare end market reported flat overall growth, with notable contributions from transplant diagnostics and immunodiagnostics [5]. Strategic Acquisitions - Thermo Fisher's growth strategy includes significant investments in acquisitions, deploying approximately $16.5 billion in 2025, with $13 billion specifically allocated for M&A [6]. - The acquisition of Clario Holdings, Inc. for $8.875 billion is expected to enhance adjusted EPS by approximately $0.45 within the first year [7]. - The company also completed the acquisition of Solventum's Purification & Filtration business for $4.1 billion, integrating it into the Life Sciences Solutions segment [7]. Challenges - Thermo Fisher's international revenue exposure makes it vulnerable to foreign currency fluctuations, which can adversely affect reported revenues and profitability [8][10]. - The company faces tough competitive pressures from a diverse range of manufacturers and distributors, necessitating ongoing research and development to adapt to changing technology and customer demands [11]. Future Outlook - The Zacks Consensus Estimate for Thermo Fisher's 2026 earnings per share remains at $24.66, with projected revenues of $46.75 billion, indicating a 4.9% increase from the previous year [12].

Core Insights - IDEX Corporation (IEX) has underperformed in operational performance, particularly in the Fluid & Metering Technologies (FMT) segment, leading to a Zacks Rank of 4 (Sell) [1] - The stock has declined by 18.3% over the past year, contrasting with the industry's growth of 9.4% [1] Business Weakness - The FMT segment is experiencing softness, particularly in agriculture, energy, water, and semiconductor markets, with organic revenues decreasing by 2% year over year in Q2 2025 [4] - Weakness in the European chemicals market is negatively impacting the chemical businesses within the FMT segment [4] Rising Expenses - Selling, general and administrative expenses increased by 11.4% year over year in Q2 2025, with amortization and professional services spending contributing to this rise [5] - As a percentage of sales, these expenses rose by 90 basis points to 23.5% in the same period [5] - The cost of sales also saw a year-over-year increase of 7.4% in Q2 2025 [5] Forex Woes - IDEX's international operations expose it to risks from adverse currency fluctuations, particularly due to a strengthening U.S. dollar, which may pressure profit margins abroad [6][8]

Core Viewpoint - Taiwan Semiconductor Manufacturing Co (TSMC) is focusing on cautious spending while expanding globally to meet the rising demand for AI chips, despite facing macroeconomic and currency risks [1][2]. Financial Performance - TSMC reported a quarterly revenue of $30.07 billion, representing a 44% year-over-year increase in USD and a 38.6% increase in New Taiwanese dollars, driven by advanced 3nm and 5nm chip technologies [3]. - Net income rose 61% year-over-year to $2.47 per share, with gross margin expanding to 58.6% and operating margin reaching 49.6% [3]. - For the third quarter, TSMC expects revenue between $31.8 billion and $33 billion, with gross margins of 55.5% to 57.5% [4]. Market Dynamics - High-performance computing and smartphone chips accounted for 87% of TSMC's revenue, with North America contributing 75% of total sales [4]. - The company is fast-tracking its Arizona projects to meet customer demand, aiming to begin production at a second plant by 2027 [2]. Analyst Insights - Needham analyst Charles Shi maintained a Buy rating on TSMC, raising the fiscal 2025 revenue growth outlook from 24-26% to approximately 30% [5]. - Shi projected third-quarter revenue of $32.4 billion and earnings per share of $2.65, indicating a positive outlook for the company [8]. - TSMC is working on pricing increases for 2026 to potentially offset foreign exchange impacts on gross margins [7].

(Exact Name of Registrant as Specified in its Charter) As filed with the U.S. Securities and Exchange Commission on September 27, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CURRENC GROUP INC. Cayman Islands 6770 98-1602649 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 410 North B ...